The In Vitro Diagnostics (IVD) Quality Control Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the In Vitro Diagnostics (IVD) Quality Control Market?
The In Vitro Diagnostics (IVD) Quality Control market has experienced substantial growth in recent times. The market size is expected to increase from $1.4 billion in 2024 to $1.49 billion in 2025, progressing at a compound annual growth rate (CAGR) of 6.5%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the In Vitro Diagnostics (IVD) Quality Control Industry?
The market size for In Vitro Diagnostics (IVD) Quality Control is projected to reach $2.09 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 8.7%.
Download Your Free Sample of the 2025 In Vitro Diagnostics (IVD) Quality Control Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the In Vitro Diagnostics (IVD) Quality Control Market?
The key drivers in the in vitro diagnostics (ivd) quality control market are:
• Advancements in personalized medicine
• Expansion of point-of-care testing
• Integration of digital health and electronic health records
• Adoption of next-generation sequencing and increasing global health security concerns
Global Market Segmentation: Identifying Major In Vitro Diagnostics (IVD) Quality Control Industry Segments
The in vitro diagnostics (IVD) quality control market covered in this report is segmented –
1) By Product type: Quality Control Products, Data Management Solutions, Quality Assurance Services
2) By Manufacturer Type: IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
3) By Application: Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
4) By End-Users: Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users
Pre-order the 2025 In Vitro Diagnostics (IVD) Quality Control Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the In Vitro Diagnostics (IVD) Quality Control Market?
The key trends in the urgent care center market are:
• Personalized medicine advancements are shaping the future of the IVD Quality Control market.
• The adoption of next-generation sequencing methods is a significant emerging trend.
• AI and machine learning applications are strategic trends influencing the IVD Quality Control market.
• The market is increasingly seeing the demand for on-demand quality control solutions and real-time feedback systems.
Who Are the Top Competitors & Leading Players in the In Vitro Diagnostics (IVD) Quality Control Market?
Major companies in the in vitro diagnostics (ivd) quality control market are:
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• LGC Limited.
• Abbott Laboratories
• Roche Diagnostics AG
• Siemens AG
• Ortho Clinical Diagnostics Inc.
• Helena Laboratories Corporation
• Quidel Corporation
• Microbiologics Inc.
• Sun Diagnostics LLC
• Fortress Diagnostics Ltd.
• Seegene Inc.
• Randox Laboratories
• Danaher Corporation
• Sysmex Corporation
• Beckman Coulter Inc.
• Grifols India Healthcare Private Limited.
• Hologic Inc.
• Qiagen NV
• Becton Dickinson and Company
• Luminex Corporation
• BioMerieux SA
• Meridian Bioscience Inc.
• Sekisui Diagnostics LLC
• ZeptoMetrix Corporation
• Maine Molecular Quality Controls Inc.
Regional Dominance: Which Area Leads the Global In Vitro Diagnostics (IVD) Quality Control Market?
North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2024
